Skip to main content

Heart Failure Therapy Could Prevent Substantial Number of Deaths, Study Finds

Provider in Home with Senior Patients Medical Team Looking at Xray

A University of California, Los Angeles study estimates that almost 28,500 deaths could be prevented each year in the US through use of a new FDA-approved class of cardiovascular medication ('angiotensin receptor neprilysin inhibitor' [ARNI] therapy) that helps reduce mortality in patients diagnosed with heart failure and reduced ejection fraction, the percentage of blood pumped from the heart with each contraction.